- Wellbutrin SR in Depression
-
Jung HY, Kim YR
- KMID: 2287349
- Korean J Psychopharmacol.
- 2005 Jan;16(1):5-15.
This article discusses the mechanism of action of Wellbutrin (bupropion) and relates the drug's neuropharmacologic effects to its clinical efficacy and side effect profiles. The preclinical and clinical data show... -
- CITED
-
- Close
- SHARE
-
- Close
- Neonatal Administration of Memantine Enhances Social Cognition in Adult Rats Subjected to Early Maternal Deprivation
-
Uribe E, Sánchez-Mendoza E, Nieves N, Merchor G
- KMID: 2362829
- Exp Neurobiol.
- 2016 Dec;25(6):328-332.
- doi: 10.5607/en.2016.25.6.328
Schizophrenia is considered a neurodevelopmental disorder; however, all the available treatment options are used when the disease becomes clinically significant in adolescence or early adulthood. Using a developmental rat model... -
- CITED
-
- Close
- SHARE
-
- Close
- Neural Network Model of Basal Ganglia: Preliminary Study
-
Choi KG
- KMID: 2342516
- J Korean Neurol Assoc.
- 1996 Jun;14(2):455-462.
A parallel distributed neural network model of basal ganglia based on the neuroanatomy, neuropharmacology and neurophysiology is described. Despite recent advances in the understanding of the pathophysiology of movement disorders,... -
- CITED
-
- Close
- SHARE
-
- Close
- Neuropharmacological Targets for Drug Action in Vestibular Sensory Pathways
-
Lee C, Jones TA
- KMID: 2394756
- J Audiol Otol.
- 2017 Sep;21(3):125-132.
- doi: 10.7874/jao.2017.00171
The use of pharmacological agents is often the preferred approach to the management of vestibular dysfunction. In the vestibular sensory pathways, the sensory neuroepithelia are thought to be influenced by... -
- CITED
-
- Close
- SHARE
-
- Close
- Neurobiology of Attention-Deficit/Hyperactivity Disorder and the Action Mechanism of OROS Methylphenidate
-
Koo YJ, Lee MS, Shin DW, Kim EJ, Kang JW, Cho SC
- KMID: 2172663
- J Korean Acad Child Adolesc Psychiatry.
- 2012 Oct;23(Suppl):S5-S11.
This article is to review neurobiology of attention-deficit/hyperactivity disorder (ADHD) and pharmacological properties of Osmotic-Controlled Release Oral delivery System Methylphenidate (OROS MPH)(Concerta Oros(R)) in celebration of its one-decade clinical experiences... -
- CITED
-
- Close
- SHARE
-
- Close
